Can post-streptococcal immune responses sustain inflammation after the infection resolves?

Group A Streptococcus (GAS) infections are unique in their ability to trigger secondary inflammatory diseases that persist long after the bacteria have been cleared from the body. These sequelae, including acute rheumatic fever (ARF) and post-streptococcal glomerulonephritis (PSGN), are driven by a transition from an acute anti-bacterial response to a sustained, self-perpetuating immune state.

Clinical and effectiveness evidence

The persistence of post-streptococcal inflammation is well-documented through clinical observation and longitudinal studies of post-infectious syndromes.

• Disease Correlates: Research indicates that the magnitude of circulating immune complexes (CICs) correlates directly with disease severity. For instance, patients with severe post-streptococcal complications exhibit significantly higher levels of CICs compared to those with mild, self-limiting infections.
• Long-term Sequelae: Clinical data confirm that even after successful antibiotic treatment of the primary infection, patients may develop chronic conditions such as rheumatic heart disease (RHD), Sydenham chorea, and PANDAS/PANS, all characterized by ongoing tissue inflammation.

Mechanistic explanations

Inflammation is sustained via two primary immunological pathways that remain active even in the absence of live bacteria:

• Molecular Mimicry: This occurs when the immune system confuses streptococcal antigens (like the M protein) with structurally similar host proteins. Antibodies initially produced to fight the infection begin attacking host tissues such as cardiac myosin, laminin, and neuronal receptors. This cross-reactivity is often exacerbated by "epitope spreading," where the immune response expands to target additional self-antigens over time.
• Immune-Complex Signaling: Streptococcal antigens can bind with host antibodies to form immune complexes. These complexes deposit in tissues—most notably the renal glomeruli—where they trigger the complement cascade and bind to Fc-gamma receptors (FcγRs) on immune cells. This signaling recruits neutrophils and macrophages, maintaining a pro-inflammatory environment through the continuous release of cytokines like TNF-α and IL-12.

Limitations and considerations

While the mechanisms of molecular mimicry and immune-complex deposition are robustly supported, individual outcomes vary based on genetic susceptibility and the history of repeated infections. In some cases, such as PSGN, the inflammation is sustained by a failure of the normal "resolution" phase, where inflammatory cells like neutrophils fail to undergo timely apoptosis, leading to prolonged tissue signaling.

Bottom line

Post-streptococcal inflammation is sustained through a combination of molecular mimicry and immune-complex signaling, which together transition a temporary infection into a persistent autoimmune or inflammatory state affecting cardiac, neurological, and renal systems.